Skip to main content

Table 3 Changes of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores at FEA from baseline

From: Intranasal budesonide for rhinitis during a high airborne pollution period: a randomized controlled trial

RQLQ (scores)a

Budesonide

(N = 103)b

Placebo

(N = 103)c

P

Total

1.45 (0.081)

1.28 (0.081)

0.142

Individual domains

 Activities

1.38 (0.093)

1.25 (0.093)

0.312

 Sleep

1.65 (0.099)

1.46 (0.099)

0.181

 Non-nose/eye symptoms

1.33 (0.086)

1.22 (0.086)

0.366

 Practical problems

1.63 (0.113)

1.51 (0.113)

0.426

 Nasal symptoms

1.67 (0.088)

1.47 (0.088)

0.109

 Eye symptoms

1.11 (0.087)

0.87 (0.087)

0.049

 Emotional

1.48 (0.099)

1.33 (0.099)

0.252

  1. aData presented as least square means (standard error)
  2. bOne subject did not finish the assessment, and one subject did not have an FEA visit
  3. cOne subject treated with placebo did not have baseline RQLQ scores
  4. Bold value indicate the P value < 0.05 with statistical significance
Back to article page